Approval · Notice of Compliance 21163 · 2018
CLONAPAM: Notice of Compliance 21163
Issued July 31, 2018
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 21163
- Date
- July 31, 2018
- Product type
- Prescription Pharmaceutical
- Submission
- Supplement to an Abbreviated New Drug Submission (SANDS), supplement
- Submission class
- Other
- Reason
- Update to the Product Monograph
- Canadian reference product
- RIVOTRIL (Hoffmann-La Roche Limited)
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| CLONAPAM | Not yet assigned | — |
Medicinal ingredients
- CLONAZEPAM 0.5 MG per TAB
- CLONAZEPAM 1 MG per TAB
- CLONAZEPAM 2 MG per TAB